Riskpilot← Back to searchSign inGet full access4DIMENS ApS
APSActiveCVR 24225674Egedal Centret 76K, 1.Research and experimental development on natural sciences and engineering · NACE 7210Est. 1999— employees
Revenue 2025
DKK 78K
EBITDA margin
-3.9%
+96% vs 2024
Equity ratio
-3725.3%
Financial strength
Net profit 2025
DKK -743K
+10% vs 2024
| Revenue | DKK 78K | — |
| EBITDA | DKK -3K | +96% |
| Net profit | DKK -743K | +10% |
| Total assets | DKK 232K | -21% |
| Equity | DKK -8,7M | +13% |
| Employees | — | — |
Legal name
4DIMENS ApS
CVR number
24225674
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. juli 1999
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at videreudvikle og at kommercialesere produkter og metoder til behandling og efterbehandling af øredeformiteter, samt at drive anden hermed forbundet virksomhed.
Address
Egedal Centret 76K, 1.
Email
info@4dimens.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 834 | 1.322 | 970 | 535 | 497 | 301 | 210 | 182 | 127 | 99 | 175 | 25 | 0 | 78 |
| Staff expenses | -0 | -22 | -29 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -57 | -231 | -29 | 4 | -88 | -84 | -173 | -195 | 2 | -170 | -126 | -119 | -75 | -3 |
| Depreciation & amort. | 209 | -216 | -216 | -215 | -208 | -201 | -201 | -201 | -201 | -170 | -59 | -59 | -59 | -59 |
| EBIT | -266 | -447 | -245 | -211 | -296 | -285 | -374 | -396 | -199 | -340 | -185 | -178 | -134 | -62 |
| Net financials | -286 | -305 | -317 | -305 | -282 | -297 | -186 | -163 | -168 | -174 | -175 | -265 | -702 | -706 |
| Profit before tax | -552 | -753 | -563 | -515 | -578 | -582 | -561 | -559 | -367 | -514 | -360 | -442 | -836 | -768 |
| Tax | -183 | -188 | 715 | -0 | -0 | -2 | -65 | -33 | -0 | -43 | -24 | -0 | -13 | -25 |
| Net profit | -548 | -564 | -1.277 | -515 | -578 | -580 | -496 | -526 | -367 | -471 | -336 | -442 | -824 | -743 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.846 | 2.783 | 1.954 | 1.649 | 1.579 | 1.237 | 1.109 | 897 | 687 | 558 | 478 | 345 | 296 | 232 |
| Equity | -2.937 | -3.501 | -4.779 | -5.294 | -5.873 | -6.452 | -6.949 | -7.475 | -7.842 | -8.313 | -8.650 | -9.092 | -9.916 | -8.659 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.783 | 6.284 | 6.733 | 6.943 | 7.452 | 7.690 | 8.058 | 8.372 | 8.529 | 8.871 | 9.128 | 9.438 | 10.212 | 8.891 |
| Total debt | 5.783 | 6.284 | 6.733 | 6.943 | 7.452 | 7.690 | 8.058 | 8.372 | 8.529 | 8.871 | 9.128 | 9.438 | 10.212 | 8.891 |
EBITDA margin
-3.9%
This company
15.8%
Market median
-125% vs market
20122025
Equity ratio
-3725.3%
This company
38.2%
Market median
-9852% vs market
20122025
Return on equity
-74289300.0%
This company
18.4%
Market median
-403746296% vs market
20122025
Net profit margin
-958.6%
This company
8.1%
Market median
-11935% vs market
20122025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20122025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KW | Audit | 2000 | — | — |
MM Management | Management | 2011 | — | — |
PM Management | Management | 2011 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 1999 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDIC COSMETIC LASER CLINIC ApS | Company | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORDIC COSMETIC LASER CLINIC ApS
4DIMENS ApS Board members of 4DIMENS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ken Woiremose Clausen | Audit | 0 companies |
| Marianne Miravet Sorribes | Management | 0 companies |
| Per Majgård | Management | 0 companies |
| Michael Miravet Sorribes | Chief Executive Officer | 0 companies |
| John Heebøll | Board of Directors | 0 companies |
| Poul Leo Anker | Board of Directors | 0 companies |
| Anne Thomas | Board of Directors | 0 companies |
| Jan Schouenborg Dombernowsky | Board of Directors | 0 companies |